| 國立成功大學 |
2023 |
Exon Junction Complex Mediates the Cap-Independent Translation of Circular RNA
|
Lin, H.-H.;Chang, Chang C.-Y.;Huang, Y.-R.;Shen, C.-H.;Wu, Y.-C.;Chang, K.-L.;Lee, Y.-C.;Lin, Y.-C.;Ting, W.-C.;Chien, H.-J.;Zheng, Y.-F.;Lai, C.-C.;Hsiao, K.-Y. |
| 國立成功大學 |
2023 |
Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists
|
Lin, T.-Y.;Kang, E.Y.-C.;Shao, Shao S.-C.;Lai, E.C.-C.;Garg, S.J.;Chen, K.-J.;Kang, J.-H.;Wu, Wu W.-C.;Lai, C.-C.;Hwang, Y.-S. |
| 臺大學術典藏 |
2022-09-07T06:39:27Z |
Nemonoxacin (TG-873870) for treatment of community-acquired pneumonia
|
Lai C.-C.; Lee K.-Y.; SHU-WEN LIN; Chen Y.-H.; Kuo H.-Y.; Hung C.-C.; Hsueh P.-R. |
| 臺大學術典藏 |
2022-09-06T02:41:32Z |
High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF-κB and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway
|
Ho F.M.; Lin W.W.; Chen B.C.; Chao C.M.; Yang C.-R.; LIAN-YU LIN; Lai C.C.; Liu S.H.; Liau C.S. |
| 臺大學術典藏 |
2022-08-12T06:28:06Z |
ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation
|
Yang J.-Y.; Zong C.S.; Xia W.; Yamaguchi H.; Ding Q.; Xie X.; Lang J.-Y.; Lai C.-C.; Chang C.-J.; Huang W.-C.; Huang H.; Kuo H.-P.; Lee D.-F.; Li L.-Y.; Lien H.-C.; Cheng X.; KING-JEN CHANG; Hsiao C.-D.; Tsai F.-J.; Tsai C.-H.; Sahin A.A.; Muller W.J.; Mills G.B.; Yu D.; Hortobagyi G.N.; Hung M.-C. |
| 臺大學術典藏 |
2022-07-20T06:33:59Z |
Effects and complications of bevacizumab use in patients with retinopathy of prematurity: A multicenter study in Taiwan
|
Wu W.-C.; PO-TING YEH; Chen S.-N.; Yang C.-M.; Lai C.-C.; Kuo H.-K. |
| 臺大學術典藏 |
2022-07-20T06:33:57Z |
An updated study of the use of bevacizumab in the treatment of patients with prethreshold retinopathy of prematurity in Taiwan
|
Wu W.-C.; Kuo H.-K.; PO-TING YEH; Yang C.-M.; Lai C.-C.; Chen S.-N. |
| 臺大學術典藏 |
2022-07-15T06:43:26Z |
Effects and complications of bevacizumab use in patients with retinopathy of prematurity: A multicenter study in Taiwan
|
Wu W.-C.; Yeh P.-T.; Chen S.-N.; CHUNG-MAY YANG; Lai C.-C.; Kuo H.-K. |
| 臺大學術典藏 |
2022-07-15T06:43:23Z |
An updated study of the use of bevacizumab in the treatment of patients with prethreshold retinopathy of prematurity in Taiwan
|
Wu W.-C.; Kuo H.-K.; Yeh P.-T.; CHUNG-MAY YANG; Lai C.-C.; Chen S.-N. |
| 臺大學術典藏 |
2022-07-15T06:43:12Z |
Clinical presentations of X-linked retinoschisis in Taiwanese patients confirmed with genetic sequencing
|
Wang N.-K.; Liu L.; Chen H.-M.; Tsai S.; Chang T.-C.; Tsai T.-H.; CHUNG-MAY YANG; Chao A.-N.; Chen K.-J.; Kao L.-Y.; Yeung L.; Yeh L.-K.; Hwang Y.-S.; Wu W.-C.; Lai C.-C. |
| 臺大學術典藏 |
2022-07-15T06:43:06Z |
Recommended guidelines for use of intravitreal aflibercept with a treat-And-extend regimen for the management of neovascular age-related macular degeneration in the Asia-pacific region: Report from a consensus panel
|
Koh A.; Lanzetta P.; Lee W.K.; Lai C.-C.; Chan W.-M.; CHUNG-MAY YANG; Cheung C.M.G. |
| 臺大學術典藏 |
2022-07-15T06:42:55Z |
Management of polypoidal choroidal vasculopathy: Experts consensus in Taiwan
|
Chen L.-J.; Cheng C.-K.; Yeung L.; Yang C.-H.; Chen S.-J.; Chen J.-T.; Chen S.-N.; Chen W.-L.; Hsu S.-M.; Hwang D.-K.; Lai C.-C.; Lai C.-H.; Lee F.-L.; CHUNG-MAY YANG; Wu T.-T.; Taiwan PCV consensus group |
| 臺大學術典藏 |
2022-07-15T06:42:46Z |
Comparison of visual outcomes between therapy choices and subtypes of polypoidal choroidal vasculopathy (PCV) in Taiwan: a real-world study
|
Yeung L.; Lai C.-C.; Chen S.-N.; Cheng C.-K.; CHUNG-MAY YANG; Hsieh Y.-T.; Tsai A.; Yang C.-H. |
| 臺大學術典藏 |
2022-07-15T06:42:43Z |
Ranibizumab reimbursement and treatment patterns for neovascular age-related macular degeneration in Taiwan – Results from the 12-month, observational RENOWNED study
|
Chen S.-N.; Lai C.-C.; Wang J.-K.; Choi H.-Y.; Kuo C.-N.; Tsai C.-Y.; Wang H.-I.; CHUNG-MAY YANG |
| 臺大學術典藏 |
2022-07-14T07:25:33Z |
Management of polypoidal choroidal vasculopathy: Experts consensus in Taiwan
|
Chen L.-J.; Cheng C.-K.; Yeung L.; CHANG-HAO YANG; Chen S.-J.; Chen J.-T.; Chen S.-N.; Chen W.-L.; Hsu S.-M.; Hwang D.-K.; Lai C.-C.; Lai C.-H.; Lee F.-L.; Yang C.-M.; Wu T.-T.; Taiwan PCV consensus group |
| 臺大學術典藏 |
2022-07-14T07:25:25Z |
Treat-and-Extend Regimens for the Management of Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy: Consensus and Recommendations From the Asia-Pacific Vitreo-retina Society
|
Chaikitmongkol V.; Sagong M.; Lai T.Y.Y.; Tan G.S.W.; Ngah N.F.; Ohji M.; Mitchell P.; CHANG-HAO YANG; Ruamviboonsuk P.; Wong I.; Sakamoto T.; Rajendran A.; Chen Y.; Lam D.S.C.; Lai C.-C.; Wong T.Y.; Cheung C.M.G.; Chang A.; Koh A. |
| 臺大學術典藏 |
2022-07-14T07:25:24Z |
Comparison of visual outcomes between therapy choices and subtypes of polypoidal choroidal vasculopathy (PCV) in Taiwan: a real-world study
|
Yeung L.; Lai C.-C.; Chen S.-N.; Cheng C.-K.; Yang C.-M.; Hsieh Y.-T.; Tsai A.; CHANG-HAO YANG |
| 臺大學術典藏 |
2022-07-14T07:25:19Z |
One-year outcomes of the treat-and-extend regimen using aflibercept for the treatment of diabetic macular edema
|
Sheu S.-J.; CHANG-HAO YANG; Lai C.-C.; Wu P.-C.; Chen S.-J. |
| 臺大學術典藏 |
2022-07-11T10:17:36Z |
Management of polypoidal choroidal vasculopathy: Experts consensus in Taiwan
|
Chen L.-J.; Cheng C.-K.; Yeung L.; Yang C.-H.; Chen S.-J.; Chen J.-T.; Chen S.-N.; Chen W.-L.; Hsu S.-M.; Hwang D.-K.; Lai C.-C.; Lai C.-H.; Lee F.-L.; CHUNG-MAY YANG; Wu T.-T.; Taiwan PCV consensus group |
| 臺大學術典藏 |
2022-07-11T10:17:28Z |
Comparison of visual outcomes between therapy choices and subtypes of polypoidal choroidal vasculopathy (PCV) in Taiwan: a real-world study
|
Yeung L.; Lai C.-C.; Chen S.-N.; Cheng C.-K.; CHUNG-MAY YANG; Hsieh Y.-T.; Tsai A.; Yang C.-H. |
| 臺大學術典藏 |
2022-07-11T10:17:25Z |
Ranibizumab reimbursement and treatment patterns for neovascular age-related macular degeneration in Taiwan �V Results from the 12-month, observational RENOWNED study
|
Chen S.-N.; Lai C.-C.; Wang J.-K.; Choi H.-Y.; Kuo C.-N.; Tsai C.-Y.; Wang H.-I.; CHUNG-MAY YANG |
| 臺大學術典藏 |
2022-07-11T09:51:05Z |
Comparison of visual outcomes between therapy choices and subtypes of polypoidal choroidal vasculopathy (PCV) in Taiwan: a real-world study
|
Yeung L.; Lai C.-C.; Chen S.-N.; Cheng C.-K.; Yang C.-M.; Hsieh Y.-T.; Tsai A.; CHANG-HAO YANG |
| 臺大學術典藏 |
2022-07-11T09:51:05Z |
Treat-and-Extend Regimens for the Management of Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy: Consensus and Recommendations From the Asia-Pacific Vitreo-retina Society
|
Chaikitmongkol V.; Sagong M.; Lai T.Y.Y.; Tan G.S.W.; Ngah N.F.; Ohji M.; Mitchell P.; CHANG-HAO YANG; Ruamviboonsuk P.; Wong I.; Sakamoto T.; Rajendran A.; Chen Y.; Lam D.S.C.; Lai C.-C.; Wong T.Y.; Cheung C.M.G.; Chang A.; Koh A. |
| 臺大學術典藏 |
2022-07-11T09:51:00Z |
One-year outcomes of the treat-and-extend regimen using aflibercept for the treatment of diabetic macular edema
|
Sheu S.-J.; CHANG-HAO YANG; Lai C.-C.; Wu P.-C.; Chen S.-J. |
| 臺大學術典藏 |
2022-06-27T07:07:41Z |
Enzyme-linked immunospot assay for interferon-gamma to support the diagnosis of tuberculosis in diabetic patients
|
Tan C.K.; Lai C.-C.; Chen H.W.; Liao C.-H.; Chou C.-H.; Huang Y.T.; Yang W.S.; CHONG-JEN YU; Hsueh P.-R. |
